Binge eating disorder is strongly associated with weight gain and obesity, though not all individuals with obesity have BED.

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

This new drug is a jab at Ozempic. Tirzepatide, a weekly injectable that rivals celebrity-favorite Wegovy, is one step closer to approval for weight loss by the Food and Drug Administration after ...

Diabetes drug Tirzepatide, which is shown to be more effective than Wegovy and Ozempic, is likely to be approved by the Food and Drug Administration for weight loss in 2023 and is expected to be ...

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and ...

To compare Ozempic and Mounjaro, Truveta analyzed medical data from over 18,000 patients who were either overweight or obese and had been prescribed semaglutide or tirzepatide for the first time ...

Tirzepatide targets both the GLP 1 and the GIP receptor agonist, ... Both Ozempic and Mounjaro are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes, ...

Weight loss medications can reduce the efficacy of oral contraceptives. What to know before taking drugs like Ozempic, ...

How Ozempic, Wegovy, Mounjaro, Zepbound May Help Treat Other Diseases: ... Tirzepatide drastically cut the risk of developing Type 2 diabetes by 94% in people with prediabetes who were also ...